Northwest Biotherapeutics, Inc. – OTC:NWBO

Northwest Biotherapeutics stock price today

$0.243
-0.03
-11.28%
Financial Health
0
1
2
3
4
5
6
7
8
9

Northwest Biotherapeutics stock price monthly change

-30.63%
month

Northwest Biotherapeutics stock price quarterly change

-30.63%
quarter

Northwest Biotherapeutics stock price yearly change

-61.94%
year

Northwest Biotherapeutics key metrics

Market Cap
755.84M
Enterprise value
628.03M
P/E
-5.99
EV/Sales
373.16
EV/EBITDA
-6.44
Price/Sales
361.70
Price/Book
-4.75
PEG ratio
0.04
EPS
-0.06
Revenue
1.33M
EBITDA
-56.84M
Income
-70.77M
Revenue Q/Q
-67.72%
Revenue Y/Y
-38.14%
Profit margin
-6240.76%
Oper. margin
-3991.74%
Gross margin
0%
EBIT margin
-3991.74%
EBITDA margin
-4254.64%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Northwest Biotherapeutics stock price history

Northwest Biotherapeutics stock forecast

Northwest Biotherapeutics financial statements

Northwest Biotherapeutics, Inc. (OTC:NWBO): Profit margin
Jun 2023 201K -14.44M -7188.06%
Sep 2023 406K -19.09M -4704.19%
Dec 2023 445K -18.91M -4251.46%
Mar 2024 284K -18.31M -6447.89%
Northwest Biotherapeutics, Inc. (OTC:NWBO): Earnings per share (EPS)
2023-02-28 -0.03 -0.03
Northwest Biotherapeutics, Inc. (OTC:NWBO): Debt to assets
Jun 2023 28438000 89.47M 314.62%
Sep 2023 31492000 96.61M 306.78%
Dec 2023 27944000 74.92M 268.11%
Mar 2024 28646000 82.03M 286.39%
Northwest Biotherapeutics, Inc. (OTC:NWBO): Cash Flow
Jun 2023 -11.52M -1.24M 8.63M
Sep 2023 -13.91M -437K 17.12M
Dec 2023 -16.95M -418K 14.41M
Mar 2024 -12.40M -239K 12.08M

Northwest Biotherapeutics alternative data

Northwest Biotherapeutics, Inc. (OTC:NWBO): Employee count
Aug 2023 22
Sep 2023 22
Oct 2023 22
Nov 2023 22
Dec 2023 22
Jan 2024 22
Feb 2024 22
Mar 2024 25
Apr 2024 25
May 2024 25
Jun 2024 25
Jul 2024 25

Northwest Biotherapeutics other data

48.61% -51.39%
of NWBO is owned by hedge funds
493.78K -2.31M
shares is hold by hedge funds

Northwest Biotherapeutics, Inc. (OTC:NWBO): Insider trades (number of shares)
Period Buy Sel
Nov 2023 0 570000
Transaction Date Insider Security Shares Price per share Total value Source
Sale
MALIK NAVID director
Common Stock 150,000 $0.82 $123,450
Sale
MALIK NAVID director
Common Stock 295,000 $0.82 $241,605
Sale
MALIK NAVID director
Common Stock 125,000 $0.84 $104,375
Sale
POWERS LINDA F director, 10 perc.. Restricted Common Stock, par value $0.001 804,146 $0.17 $136,705
Sale
POWERS LINDA F director, 10 perc.. Restricted Common Stock, par value $0.001 3,558,639 $0.17 $604,969
Sale
POWERS LINDA F director, 10 perc.. Class D-2 Warrants 1,779,320 N/A N/A
Option
BOSCH MARNIX L officer: Chief Technical Officer
Employee Stock Option (Right to Buy) 7,940,182 $0.25 $1,985,046
Sale
COGNATE BIOSERVICES, INC. 10 percent owner
Common Stock, par value $0.001 1,118,092 $4.22 $4,718,348
Sale
COGNATE BIOSERVICES, INC. 10 percent owner
Common Stock, par value $0.001 650,000 $4 $2,600,000
Sale
COGNATE BIOSERVICES, INC. 10 percent owner
Common Stock 149,502 $5.02 $750,500
Thursday, 26 December 2024
prnewswire.com
Wednesday, 3 July 2024
prnewswire.com
Monday, 17 June 2024
prnewswire.com
Thursday, 21 March 2024
prnewswire.com
Tuesday, 6 February 2024
prnewswire.com
Wednesday, 22 November 2023
prnewswire.com
Saturday, 14 October 2023
Seeking Alpha
Thursday, 17 August 2023
Seeking Alpha
Thursday, 1 December 2022
24/7 Wall Street
InvestorPlace
Wednesday, 23 November 2022
Seeking Alpha
Monday, 8 August 2022
Seeking Alpha
Saturday, 21 May 2022
Seeking Alpha
Saturday, 5 March 2022
Seeking Alpha
Thursday, 27 January 2022
PennyStocks
  • What's the price of Northwest Biotherapeutics stock today?

    One share of Northwest Biotherapeutics stock can currently be purchased for approximately $0.24.

  • When is Northwest Biotherapeutics's next earnings date?

    Unfortunately, Northwest Biotherapeutics's (NWBO) next earnings date is currently unknown.

  • Does Northwest Biotherapeutics pay dividends?

    No, Northwest Biotherapeutics does not pay dividends.

  • How much money does Northwest Biotherapeutics make?

    Northwest Biotherapeutics has a market capitalization of 755.84M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 14.8% to 1.93M US dollars. Northwest Biotherapeutics made a loss 62.6M US dollars in net income (profit) last year or -$0.03 on an earnings per share basis.

  • What is Northwest Biotherapeutics's stock symbol?

    Northwest Biotherapeutics, Inc. is traded on the OTC under the ticker symbol "NWBO".

  • What is Northwest Biotherapeutics's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Northwest Biotherapeutics?

    Shares of Northwest Biotherapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Northwest Biotherapeutics's key executives?

    Northwest Biotherapeutics's management team includes the following people:

    • Ms. Linda F. Powers J.D. Chairperson, Chief Executive Officer, Pres, Chief Financial Officer & Chief Accounting Officer(age: 69, pay: $700,000)
    • Mr. Leslie J. Goldman Senior Vice President & Gen. Counsel(age: 80, pay: $525,000)
    • Dr. Marnix L. Bosch M.B.A., Ph.D., MBA Chief Technical Officer(age: 66, pay: $480,000)
  • How many employees does Northwest Biotherapeutics have?

    As Jul 2024, Northwest Biotherapeutics employs 25 workers.

  • When Northwest Biotherapeutics went public?

    Northwest Biotherapeutics, Inc. is publicly traded company for more then 23 years since IPO on 14 Dec 2001.

  • What is Northwest Biotherapeutics's official website?

    The official website for Northwest Biotherapeutics is nwbio.com.

  • Where are Northwest Biotherapeutics's headquarters?

    Northwest Biotherapeutics is headquartered at 4800 Montgomery Lane, Bethesda, MD.

  • How can i contact Northwest Biotherapeutics?

    Northwest Biotherapeutics's mailing address is 4800 Montgomery Lane, Bethesda, MD and company can be reached via phone at +240 4979024.

Northwest Biotherapeutics company profile:

Northwest Biotherapeutics, Inc.

nwbio.com
Exchange:

OTC

Full time employees:

19

Industry:

Biotechnology

Sector:

Healthcare

Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, which is in Phase I/II clinical trials to treat inoperable solid tumors. The company was founded in 1996 and is headquartered in Bethesda, Maryland.

4800 Montgomery Lane
Bethesda, MD 20814

CIK: 0001072379
ISIN: US66737P6007
: